(Q42984161)

12 November 2017

title

Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation (English)

1 reference

12 November 2017

1 reference

liver transplantation

1 reference

1 reference

9

Pierre-Alain Clavien

1 reference

12 November 2017

Emiliano Giostra

1

1 reference

12 November 2017

Gerd A Kullak-Ublick

2

1 reference

12 November 2017

Walter Keller

3

1 reference

12 November 2017

Ronald Fried

4

1 reference

12 November 2017

Claire Vanlemmens

5

1 reference

12 November 2017

Stephan Kraehenbuhl

6

1 reference

12 November 2017

Sandrine Locher

7

1 reference

12 November 2017

Hans-Peter Egger

8

1 reference

12 November 2017

Antoine Hadengue

10

1 reference

12 November 2017

Gilles Mentha

11

1 reference

12 November 2017

Philippe Morel

12

1 reference

12 November 2017

Francesco Negro

13

1 reference

12 November 2017

publication date

2 April 2004

1 reference

12 November 2017

published in

Transplant International

1 reference

12 November 2017

volume

17

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

169-176

1 reference

Long-term outcome of hepatitis C infection after liver transplantation

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Incidence and treatment of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Immunological and virological effects of ribavirin in hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00424.X

10.1111/J.1432-2277.2004.TB00424.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference